Title Čimbenici rizika hipertoniciteta faringoezofagealnog segmenta nakon totalne laringektomije
Title (english) Risk factors for hypertonicity of the pharyngoesophageal segment after total laryngectomy
Author Ivana Kero
Mentor Maja Rogić Vidaković (mentor)
Committee member Marisa Klančnik (predsjednik povjerenstva)
Committee member Ivana Pavlinac Dodig (član povjerenstva)
Committee member Snježana Mardešić (član povjerenstva)
Granter University of Split School of Medicine Split
Defense date and country 2024-07-18, Croatia
Scientific / art field, discipline and subdiscipline BIOMEDICINE AND HEALTHCARE Clinical Medical Sciences Otorhinolaryngology
Abstract Cilj istraživanja: Cilj je ovog istraživanja bio analizirati čimbenike rizika za razvoj hipertoniciteta (spazma) faringoezofagealnog segmenta u bolesnika podvrgnutih totalnoj laringektomiji.
Materijali i metode: Retrospektivno istraživanje provedeno je u Klinici za bolesti uha, nosa i grla s kirurgijom glave i vrata Kliničkog bolničkog centra Split. Obrađeni su podaci iz medicinske dokumentacije bolesnika liječenih totalnom laringektomijom zbog pločastog karcinoma grkljana u razdoblju od 1. siječnja 2020. do 31. prosinca 2023. godine. Bolesnici su bili podijeljeni u dvije skupine: skupina s hipertonicitetom (5 bolesnika) i skupina bez hipertoniciteta (24 bolesnika). Analiziralo se 20 varijabli podijeljenih slijedeće skupine: demografski podaci (dob, spol), podaci iz osobne anamneze (komorbiditeti, kronična farmakoterapija, druge maligne bolesti), podaci vezano za životne navike (pušenje cigareta, konzumacija alkohola), simptomi prilikom postavljanja dijagnoze, patohistološki nalazi, modalitet liječenja (tip operacije, adjuvantna radioterapija).
Rezultati: U ispitivanoj skupini svi su bolesnici s razvijenim hipertonicitetom faringoezofagealnog segmenta bili muškog spola. Prosječna je dob pri postavljanju dijagnoze hipertoniciteta bila 69,2 godina. 60% bolesnika s hipertonicitetom imalo je prisutnu i drugu malignu bolest u anamnezi, ali negativnu obiteljsku anamnezu na maligne bolesti. U patohistološkom nalazu limfovaskularna invazija (LVI) tumora bila je češće prisutna u bolesnika s hipertonicitetom (80%) u odnosu na kontrolne skupine (47% i 28,5%). Dokazana je statistički značajna razlika u učestalosti aktivnog pušenja duhanskih proizvoda u skupini s hipertonicitetom (60%), u odnosu na kontrolnu skupinu bez hipertoniciteta s izvršenom krikofaringealnom miotomijom (5%) (P=0,01). Izloženost adjuvantnoj radioterapiji kao ni tip operacije nisu se pokazali značajnima u povećanju rizika za razvoj hipertoniciteta faringoezofagealnog segmenta (adjuvantna radioterapija P=0,62 i P=0,84; tip operacije P=0,64 i P=0,12).
Zaključak: Spolna i dobna raspodjela hipertoniciteta faringoezofagealnog segmenta korelira s podacima iz svjetske literature. Aktivno pušenje cigareta može povećati rizik razvoja hipertoniciteta. Potrebna su dodatna istraživanja kako bi se sa sigurnošću utvrdili čimbenici rizika te utjecaj konzumacije duhanskih proizvoda, radioterapije i vrste kirurškog zahvata na pojavu hipertoniciteta faringoezofagealnog segmenta.
Abstract (english) Objectives: The aim of this research was to analyze risk factors for the development of hypertonicity (spasm) of the pharyngoesophageal segment in patients undergoing total laryngectomy.
Subjects and methods: A retrospective study was conducted at the Department of Ear, Nose and Throat with Head and Neck Surgery at University Hospital of Split. Data from the medical records of patients treated with total laryngectomy for squamous cell laryngeal carcinoma in the period from January 1, 2020 to December 31, 2023 were processed. The patients were divided into two groups: a group with hypertonicity (5 patients) and a group without hypertonicity (24 patients). 20 variables were analyzed, divided into the following groups: demographic data (age, gender), data from medical history (comorbidities, chronic pharmacotherapy, other malignant diseases), data related to lifestyle (cigarette smoking, alcohol consumption), symptoms at the time of diagnosis, pathohistological findings, treatment modality (type of surgery, adjuvant radiotherapy).
Results: In the examined group, all patients with developed hypertonicity of the pharyngoesophageal segment were male. The average age at diagnosis of hypertonicity was 69.2 years. 60% of patients with hypertonicity also had a history of another malignant disease, but a negative family history of malignant neoplasm. In the pathohistological findings, lymphovascular invasion (LVI) was more often present in patients with hypertonicity (80%) compared to control groups (47% and 28.5%). A statistically significant difference was shown in the frequency of active smoking of tobacco products in the group with hypertonicity (60%), compared to the control group without hypertonicity with cricopharyngeal myotomy (5%) (P=0.01). Exposure to adjuvant radiotherapy, as well as the type of surgery, did not prove to be significant in increasing the risk of developing hypertonicity of the pharyngoesophageal segment (adjuvant radiotherapy P=0.62 and P=0.84; type of surgery P=0.64 and P=0.12).
Conclusion: Gender and age distribution of hypertonicity of the pharyngoesophageal segment correlates with data from global literature. Active cigarette smoking could increase the risk of developing hypertonicity. Additional research is needed in order to determine with certainty the risk factors and the influence of the consumption of tobacco products, radiotherapy and the type of surgery on the occurrence of hypertonicity of the pharyngoesophageal segment.
Keywords
hipertonicitet faringoezofagealnog segmenta
totalna laringektomija
botulinum toksin A
Keywords (english)
hypertonicity of the pharyngoesophageal segment
total laryngectomy
botulinum toxin A
Language croatian
URN:NBN urn:nbn:hr:171:302005
Study programme Title: Medicine Study programme type: university Study level: integrated undergraduate and graduate Academic / professional title: doktor/doktorica medicine (doktor/doktorica medicine)
Type of resource Text
File origin Born digital
Access conditions Open access Embargo expiration date: 2024-07-18
Terms of use
Created on 2024-07-18 08:11:48